|
| Exchange Received Time 27/07/2018 13:48:54 Exchange Disseminated Time 27/07/2018 13:49:01 Time Taken 00:00:07 | With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended on 30th June, 2018.
We enclose herewith the following:
a) Consolidated Unaudited Financial Results for the quarter ended on 30th June, 2018.
b) Standalone Unaudited Financial Results for the quarter ended on 30th June, 2018.
c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results.
d) Press Release.
e) Investor Presentation.
The time of commencement of the reconvened Board Meeting on 27th July, 2018 was 11:00 a.m. and the time of conclusion was 1:30 p.m.
|
|
|